BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30550341)

  • 1. Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics.
    Walczak J; Dębska-Vielhaber G; Vielhaber S; Szymański J; Charzyńska A; Duszyński J; Szczepanowska J
    FASEB J; 2019 Mar; 33(3):4388-4403. PubMed ID: 30550341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered age-related changes in bioenergetic properties and mitochondrial morphology in fibroblasts from sporadic amyotrophic lateral sclerosis patients.
    Allen SP; Duffy LM; Shaw PJ; Grierson AJ
    Neurobiol Aging; 2015 Oct; 36(10):2893-903. PubMed ID: 26344876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary fibroblasts derived from sporadic amyotrophic lateral sclerosis patients do not show ALS cytological lesions.
    Codron P; Cassereau J; Vourc'h P; Veyrat-Durebex C; Blasco H; Kane S; Procaccio V; Letournel F; Verny C; Lenears G; Reynier P; Chevrollier A
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):446-456. PubMed ID: 29382228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis.
    Joshi AU; Saw NL; Vogel H; Cunnigham AD; Shamloo M; Mochly-Rosen D
    EMBO Mol Med; 2018 Mar; 10(3):. PubMed ID: 29335339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.
    Konrad C; Kawamata H; Bredvik KG; Arreguin AJ; Cajamarca SA; Hupf JC; Ravits JM; Miller TM; Maragakis NJ; Hales CM; Glass JD; Gross S; Mitsumoto H; Manfredi G
    Mol Neurodegener; 2017 Oct; 12(1):76. PubMed ID: 29065921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulated mitochondrial Ca
    Zhou J; Li A; Li X; Yi J
    Arch Biochem Biophys; 2019 Mar; 663():249-258. PubMed ID: 30682329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.
    Sharma A; Varghese AM; Vijaylakshmi K; Sumitha R; Prasanna VK; Shruthi S; Chandrasekhar Sagar BK; Datta KK; Gowda H; Nalini A; Alladi PA; Christopher R; Sathyaprabha TN; Raju TR; Srinivas Bharath MM
    Neurochem Res; 2016 May; 41(5):965-84. PubMed ID: 26646005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.
    Araujo BG; Souza E Silva LF; de Barros Torresi JL; Siena A; Valerio BCO; Brito MD; Rosenstock TR
    Mol Neurobiol; 2020 Dec; 57(12):5084-5102. PubMed ID: 32840822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superoxide dismutase 1 mutation in a cellular model of amyotrophic lateral sclerosis shifts energy generation from oxidative phosphorylation to glycolysis.
    Allen SP; Rajan S; Duffy L; Mortiboys H; Higginbottom A; Grierson AJ; Shaw PJ
    Neurobiol Aging; 2014 Jun; 35(6):1499-509. PubMed ID: 24439480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated.
    Singh T; Jiao Y; Ferrando LM; Yablonska S; Li F; Horoszko EC; Lacomis D; Friedlander RM; Carlisle DL
    Sci Rep; 2021 Sep; 11(1):18916. PubMed ID: 34556702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.
    Manfredi G; Xu Z
    Mitochondrion; 2005 Apr; 5(2):77-87. PubMed ID: 16050975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis.
    Shrivastava M; Vivekanandhan S; Pati U; Behari M; Das TK
    Int J Neurosci; 2011 Mar; 121(3):149-58. PubMed ID: 21138397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria in sporadic amyotrophic lateral sclerosis.
    Swerdlow RH; Parks JK; Cassarino DS; Trimmer PA; Miller SW; Maguire DJ; Sheehan JP; Maguire RS; Pattee G; Juel VC; Phillips LH; Tuttle JB; Bennett JP; Davis RE; Parker WD
    Exp Neurol; 1998 Sep; 153(1):135-42. PubMed ID: 9743575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mitochondrial bioenergetics, dynamics, endoplasmic reticulum-mitochondria crosstalk, and reactive oxygen species in fibroblasts from patients with complex I deficiency.
    Leipnitz G; Mohsen AW; Karunanidhi A; Seminotti B; Roginskaya VY; Markantone DM; Grings M; Mihalik SJ; Wipf P; Van Houten B; Vockley J
    Sci Rep; 2018 Jan; 8(1):1165. PubMed ID: 29348607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control.
    Palomo GM; Manfredi G
    Brain Res; 2015 May; 1607():36-46. PubMed ID: 25301687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial oxidative phosphorylation transcriptome alterations in human amyotrophic lateral sclerosis spinal cord and blood.
    Ladd AC; Keeney PM; Govind MM; Bennett JP
    Neuromolecular Med; 2014 Dec; 16(4):714-26. PubMed ID: 25081190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of SIGMAR1 gene mutation and mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Fukunaga K; Shinoda Y; Tagashira H
    J Pharmacol Sci; 2015 Jan; 127(1):36-41. PubMed ID: 25704016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts.
    Sala G; Trombin F; Mattavelli L; Beretta S; Tremolizzo L; Andreoni S; Calabrese E; Sanvito L; Ferrarese C
    Neurodegener Dis; 2009; 6(1-2):9-15. PubMed ID: 18349520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabo-lipidomics of Fibroblasts and Mitochondrial-Endoplasmic Reticulum Extracts from ALS Patients Shows Alterations in Purine, Pyrimidine, Energetic, and Phospholipid Metabolisms.
    Veyrat-Durebex C; Bris C; Codron P; Bocca C; Chupin S; Corcia P; Vourc'h P; Hergesheimer R; Cassereau J; Funalot B; Andres CR; Lenaers G; Couratier P; Reynier P; Blasco H
    Mol Neurobiol; 2019 Aug; 56(8):5780-5791. PubMed ID: 30680691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration induced by complex I inhibition in a cellular model of familial amyotrophic lateral sclerosis.
    Rizzardini M; Lupi M; Mangolini A; Babetto E; Ubezio P; Cantoni L
    Brain Res Bull; 2006 Apr; 69(4):465-74. PubMed ID: 16624679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.